24The 2019 novel severe respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak 25 has caused a large number of deaths with thousands of confirmed cases worldwide. The present 26 study followed computational approaches to identify B-and T-cell epitopes for spike 27 glycoprotein of SARS-CoV-2 by its interactions with the human leukocyte antigen alleles. We 28 identified twenty-four peptide stretches on the SARS-CoV-2 spike protein that are well 29 conserved among the reported strains. The S protein structure further validated the presence of 30 predicted peptides on the surface. Out of which twenty are surface exposed and predicted to 31 have reasonable epitope binding efficiency. The work could be useful for understanding the 32 immunodominant regions in the surface protein of SARS-CoV-2 and could potentially help in 33 designing some peptide-based diagnostics. 34 35 36 37 38 39 40 41 42 43 44 45 46 47Emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recent 51 pandemic and declared as a public health emergency by World Health Organization (WHO) 1 .
52The disease rapidly spread across the globe and caused havoc to humanity 2 . By the end of 53 March, SARS-CoV-2 had spread to 200 countries and infected over 4,50,000 people 3 . The 54 WHO is continuously monitoring and updating the health-related plans to curtail the disease 55 spread. The absence of specific treatment and vaccine worsen the situation and threat the world. 56 International Committee on Taxonomy of Viruses (ICTV), classified SARS-CoV-2 57 under family coronaviridae of order nidovirales. The genomic sequence of SARS-CoV-2 58 isolated from the bronchoalveolar lavage fluid of a patient from the Wuhan, China showed a 59 length of 29,903 nucleotides (GenBank accession number NC_045512) 4 . The SARS-CoV-2 60 contains a positive single-stranded RNA with 5ˊ and 3ˊ UTR. The genome codes for ORF1a, 61 ORF1b, Spike (S), ORF3a, ORF3b, Envelope (E), Membrane (M), ORF6, ORF7a, ORF7b, 62ORF8, ORF9b, ORF14, Nucleocapsid (N), and ORF10 from 5ˊ to 3ˊ 4,5 .
63The S glycoprotein forms homotrimers and represents a potential target for therapeutic 64 and vaccine design as it mediates viral entry into host cells 6,7 . S glycoprotein comprises of two 65 functional subunits. Whereas the S1 subunit is responsible for binding to the host cell receptor, 66 the S2 subunit is responsible for the fusion of the viral with the cell membrane. Usually, in 67 CoVs, S is cleaved at the boundary between the S1 and S2 subunits, which remain non-68 covalently bound in the prefusion conformation, to activate the protein for membrane fusion 69 via extensive irreversible conformational changes [8][9][10] . Setting apart from other SARS-CoVs, it 70 is found that S glycoprotein of SARS-CoV-2 harbors a furin cleavage site at the boundary 71 between the S1/S2 subunits 11 . By now, it is evident that SARS-CoV-2 S uses angiotensin-72 converting enzyme 2 (ACE2) receptor-mediated entry into cells. It is found that the receptor-73 was not certified by peer review) is th...